AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al > Summary
Court Case Number 1:20-cv-01180
Filing Date Sep 3, 2020
Termination Date Oct 26, 2020
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Plaintiff
Plaintiff Attorneys
7AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Mark J. Feldstein
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Jill K. MacAlpine
Finnegan, Henderson, Farabow, Garrett & Dunner
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10300065 | Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction | May 28, 2019 |